Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00063648 |
Recruitment Status
:
Completed
First Posted
: July 3, 2003
Last Update Posted
: January 13, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Liver Disease Lymphoproliferative Disorders | Biological: EBV-specific autologous CTL | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 50 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Study Start Date : | May 2002 |
Study Completion Date : | December 2007 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Month to 21 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00063648
United States, Texas | |
Texas Children's Hospital | |
Houston, Texas, United States, 77030 |
ClinicalTrials.gov Identifier: | NCT00063648 History of Changes |
Other Study ID Numbers: |
PTLD (completed) |
First Posted: | July 3, 2003 Key Record Dates |
Last Update Posted: | January 13, 2010 |
Last Verified: | January 2010 |
Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
PTLD CTL Therapy Post-transplant lymphoproliferative disorder |
Additional relevant MeSH terms:
Liver Diseases Lymphoproliferative Disorders Digestive System Diseases |
Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases |